Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v2-FR
Language French French
Date Updated 2019-08-15 2019-08-13
Drug Identification Number 02409135 02409135
Brand name INTUNIV XR INTUNIV XR
Common or Proper name guanfacine hydrochloride extended-release tablets guanfacine hydrochloride extended-release tablets
Company Name SHIRE PHARMA CANADA ULC SHIRE PHARMA CANADA ULC
Ingredients Guanfacine Guanfacine
Strength(s) 4MG 4MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 Tablets / Bottle 100 Tablets / Bottle
ATC code C02AC C02AC
ATC description ANTIADRENERGIC AGENTS, CENTRALLY ACTING ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-08-13 2019-08-13
Actual start date 2019-08-13
Estimated end date 2019-09-30 2019-09-30
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments Product allocation on a temporary basis Product allocation on a temporary basis
Health Canada comments